First Step to Success: Complete Screening Checklist for Intended Parents Before Mexico IVF

Embarking on the Mexico IVF journey requires a comprehensive fertility check, which is the first step to ensuring treatment success and the key basis for POWER IVF to tailor a personalized stimulation protocol for intended parents. IVF screening projects are not only conducted to confirm the cause of infertility but also to rule out any potential risks that could affect the success rate and future health of the pregnancy. POWER FERTILITY CLINIC experts advise that intended parents should complete the following crucial tests before starting Mexico IVF.

 Key Screening Projects for Female Intended Parents

The focus for female screening is to evaluate ovarian function, the uterine environment, and exclude infectious diseases.

1.  Ovarian Reserve Function Assessment

     AMH (Anti-Müllerian Hormone): This is the most important indicator for assessing ovarian reserve function, reflecting the number of eggs.

     Basal Hormone Levels: Checked on day 2 or 3 of the menstrual cycle (including FSH, LH, E2, etc.) to predict the ovary's response to stimulation medications.

     Antral Follicle Count (AFC): Counting the number of antral follicles via transvaginal ultrasound directly reflects the potential for egg retrieval in the current cycle.

2.  Uterine Environment and Fallopian Tube Check

     Uterine Ultrasound: Assesses uterine morphology, endometrial thickness, and checks for fibroids or polyps, ensuring the uterine environment is suitable for transfer (if the intended parent is carrying the pregnancy).

     Fallopian Tube Patency: Although IVF bypasses the fallopian tubes, if severe hydrosalpinx is present, fluid may flow back into the uterine cavity, affecting embryo implantation and requiring prior treatment.

3.  Infectious Disease and Genetic Screening

     Infectious Disease Panel: Includes tests for Hepatitis B, Hepatitis C, Syphilis, HIV, etc., to ensure the safety of the reproductive process.

     Chromosomal Karyotyping: Rules out genetic factors that may lead to recurrent miscarriage or IVF failure.

 Key Screening Projects for Male Intended Parents

The focus for male screening is on sperm quality and excluding infectious diseases.

1.  Semen Analysis

     This is the main test for males, evaluating sperm count, motility, and morphology, which is crucial for determining whether conventional IVF or ICSI (Intracytoplasmic Sperm Injection) will be used.

     Sperm DNA Fragmentation Index (DFI): If DFI is high, it may affect embryo quality and implantation, requiring pre-treatment intervention.

2.  Infectious Disease and Genetic Screening

     Consistent with female screening, an infectious disease panel must be performed.

     If semen quality is extremely poor, genetic tests such as chromosomal karyotyping or Y-chromosome microdeletion screening may be required.

Accurate screening is the foundation for customizing a high-success-rate treatment plan. These steps not only provide POWER FERTILITY CLINIC with the most detailed clinical data but also give intended parents a clear blueprint of their health, ensuring confidence and certainty throughout the entire process.

Power Fertility Center stands as a premier fertility hub in the U.S. and Mexico, operated under U.S. IVF standards for top-tier care. Located with cutting-edge embryology labs in both nations, Power IVF delivers one-stop fertility services—IVF, IUI, sex selection, U.S. egg freezing, sperm freezing, egg donation, sperm donation, embryo donation, and surrogacy—to singles, couples, and LGBTQ communities. It offers IVF-PGT and fertility preparation support in Japan, Thailand, Taiwan, and beyond. With advanced tech and a warm, tailored approach, Power IVF’s Guarantee Program in Mexico ensures live births via egg donation and surrogacy, backed by 24/7 patient care.